Skip to main content
DXCM
NASDAQ Life Sciences

Dexcom G7 Monitor Shows Significant Blood Sugar Reduction in Non-Insulin Type 2 Diabetics

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$71.5
Mkt Cap
$28.115B
52W Low
$54.11
52W High
$89.98
52W Position info
32% above low
Off High info
21% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

DXCM sits 32% above its 52-week low of $54.11.

Summary

Dexcom's G7 continuous glucose monitor demonstrated significant benefits in a 26-week study of non-insulin dependent Type 2 diabetic patients. Participants using the G7 saw an average 1.6% reduction in blood sugar levels, a 0.9% greater reduction than those using self-monitoring. This positive clinical data is crucial as it could lead to an expansion of the standard of care and insurance coverage for CGMs to a much larger patient population, substantially increasing Dexcom's addressable market. The company expects this to influence both the clinical community and payers. A six-month extension phase of the study is currently underway.

At the time of this announcement, DXCM was trading at $71.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.1B. The 52-week trading range was $54.11 to $89.98. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

DXCM - Latest Insights

DXCM
Oct 29, 2026, 5:22 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $81.30
Real-time Price: $81.80 info
Change: +$0.500 (+0.62%) info
Market Cap: $30.597B info
DXCM
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.20
Real-time Price: $81.80 info
Change: +$2.60 (+3%) info
Market Cap: $30.597B info
DXCM
Oct 29, 2026, 4:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $79.93
Real-time Price: $81.80 info
Change: +$1.87 (+2%) info
Market Cap: $30.597B info
DXCM
Oct 15, 2026, 10:04 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $87.85
Real-time Price: $81.80 info
Change: -$6.05 (-7%) info
Market Cap: $30.597B info
DXCM
Jul 30, 2026, 5:21 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $80.39
Real-time Price: $81.80 info
Change: +$1.41 (+2%) info
Market Cap: $30.597B info